Market Overview

HubSpot Neutral At Goldman On Slowing Customer Acquisition


Although HubSpot Inc (NYSE: HUBS) seems poised for sustained growth and margin expansion, the stock appears fairly valued, given decelerating gross customer additions in the company’s marketing business and the relatively small size of the sales business, Goldman Sachs’ Jesse Hulsing said in a report. He initiated coverage of HubSpot with a Neutral rating and a 12-month price target of $57.

The price target implies 1 percent downside risk versus the GS coverage group average of 3 percent upside, analyst Hulsing noted.

Growth Drivers

“HUBS has steadily moved down the marketing funnel, expanding from content management to marketing automation and, more recently, to salesforce automation,” Hulsing wrote. He added that HubSpot’s integrated approach to SMB CRM would likely result in continued share gains and estimated a 35 percent subscription revenue CAGR through FY18.

Slowing Growth

The company’s marketing business is expected to have recorded 8 percent y/y growth in gross customer adds in the first half 2016, representing a massive slowdown from the 35 percent y/y growth reported in the same period in 2015.

Given the slowdown in gross adds growth, incremental growth would need to be generated from sales and upselling or cross-selling within the marketing base, the analyst stated. The sales business is still small, contributing only 4 percent of ARR as of Q2.

Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!

Latest Ratings for HUBS

Aug 2019Initiates Coverage OnBuy
Aug 2019MaintainsEqual-Weight
Jun 2019Initiates Coverage OnBuy

View More Analyst Ratings for HUBS
View the Latest Analyst Ratings

Posted-In: Goldman Sachs Jesse HulsingAnalyst Color Initiation Analyst Ratings


Related Articles (HUBS)

View Comments and Join the Discussion!

Latest Ratings

View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Sarepta Wins Exclusive License, Collaboration Deal for European Rights To Summit's DMD Drug

15 Stocks Moving In Tuesday's Pre-Market Session